Evidence map›Paper›PMID 38921532›Full record

ReviewJournal of functional biomaterials2024

Progress in Core-Shell Magnetic Mesoporous Materials for Enriching Post-Translationally Modified Peptides.

Zhenyu Zhu, Hang Fu, Yu Zhao, Qiulin Yan

Abstract readReview
In one paragraph

Review in Journal of functional biomaterials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhenyu ZhuIsotopomics in Chemical Biology (ICB), College of Chemistry & Chemical Engineering, Shaanxi University of Science and Technology, Xi'an 710021, China.ORCID 0000-0002-8750-8987
Hang FuIsotopomics in Chemical Biology (ICB), College of Chemistry & Chemical Engineering, Shaanxi University of Science and Technology, Xi'an 710021, China.ORCID 0009-0007-4003-9945
Yu ZhaoIsotopomics in Chemical Biology (ICB), College of Chemistry & Chemical Engineering, Shaanxi University of Science and Technology, Xi'an 710021, China.
Qiulin YanIsotopomics in Chemical Biology (ICB), College of Chemistry & Chemical Engineering, Shaanxi University of Science and Technology, Xi'an 710021, China.ORCID 0009-0003-3090-9178

Funding

National Natural Science Foundation of China 32071507
6 · The paper itself

Abstract

Endogenous peptides, particularly those with post-translational modifications, are increasingly being studied as biomarkers for diagnosing various diseases. However, they are weakly ionizable, have a low abundance in biological samples, and may be interfered with by high levels of proteins, peptides, and other macromolecular impurities, resulting in a high limit of detection and insufficient amounts of post-translationally modified peptides in real biological samples to be examined. Therefore, separation and enrichment are necessary before analyzing these biomarkers using mass spectrometry. Mesoporous materials have regular adjustable pores that can eliminate large proteins and impurities, and their large specific surface area can bind more target peptides, but this may result in the partial loss or destruction of target peptides during centrifugal separation. On the other hand, magnetic mesoporous materials can be used to separate the target using an external magnetic field, which improves the separation efficiency and yield. Core-shell magnetic mesoporous materials are widely utilized for peptide separation and enrichment due to their biocompatibility, efficient enrichment capability, and excellent recoverability. This paper provides a review of the latest progress in core-shell magnetic mesoporous materials for enriching glycopeptides and phosphopeptides and compares their enrichment performance with different types of functionalization methods.

Indexed as

core–shell structureendogenous peptidesenrichmentmagnetic mesoporous materialspost-translational modification

Identifiers

PMID38921532
PMCPMC11205187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.